Related Experiment Video
Updated: Nov 20, 2025

07:14
A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
9.6K
Pain sensitivity and shoulder function among breast cancer survivors compared to matched controls: a case-control
G H F Rasmussen1, P Madeleine2, M Arroyo-Morales3
1Sport Sciences - Performance and Technology, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark. ghfr@hst.aau.dk.
Journal of Cancer Survivorship : Research and Practice
|January 26, 2021
Summary
Breast cancer survivors (BCS) with persistent pain show reduced shoulder strength and range of motion compared to controls. This persistent pain, even years after treatment, may indicate central sensitization and benefit from tailored rehabilitation.
Area of Science:
- Oncology
- Pain Medicine
- Rehabilitation Science
Background:
- Persistent pain and impaired shoulder function are common after breast cancer treatment (BCS).
- The long-term impact on shoulder function and pain sensitivity in survivors beyond 1.5 years post-treatment remains unclear compared to healthy individuals.
Purpose of the Study:
- To compare pressure pain thresholds (PPTs), maximal isokinetic muscle strength (MIMS), and active range of motion (ROM) in female BCS with persistent pain (≥1.5 years post-treatment) against pain-free matched controls (CON).
- To investigate movement-evoked pain (MEP) during MIMS assessment in BCS survivors.
Main Methods:
- Assessed PPTs at 18 locations using a pressure algometer.
- Measured active ROM with a universal goniometer and MIMS with an isokinetic dynamometer.
- Quantified MEP intensity using a numeric rating scale.
Main Results:
- BCS survivors exhibited significantly lower PPTs across all locations compared to CON.
- Significant reductions in MIMS (shoulder extension/flexion, adduction) and active ROM (flexion, horizontal extension, abduction, external rotation) were observed in BCS survivors.
- BCS survivors reported significantly higher MEP, which negatively correlated with PPTs.
Conclusions:
- Female breast cancer survivors with persistent pain ≥1.5 years post-treatment demonstrate widespread reductions in PPTs and specific deficits in shoulder MIMS and active ROM.
- The presence of MEP during physical assessment suggests central sensitization in these survivors.
- Individualized rehabilitation strategies may be beneficial for BCS survivors experiencing persistent pain and functional deficits.

